Want to see NVST full AI Analyst Report?
NVST Stock Chart & Stats
$26.33
$0.16(0.61%)
At close: 4:00 PM EDT
$26.33
$0.16(0.61%)
Day’s Range― - ―
52-Week Range$18.77 - $30.42
Previous Close$26.33
Volume1.86M
Average Volume (3M)2.47M
Market Cap
$4.44B
Enterprise Value$4.80K
Total Cash (Recent Filing)$1.08B
Total Debt (Recent Filing)$1.59B
Price to Earnings (P/E)65.0
Beta1.03
Next Earnings
Aug 05, 2026EPS Estimate
0.34Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.42
Shares Outstanding162,727,920
10 Day Avg. Volume2,146,837
30 Day Avg. Volume2,470,277
Financial Highlights & Ratios
PEG Ratio-0.74
Price to Book (P/B)1.17
Price to Sales (P/S)1.34
P/FCF Ratio15.83
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda<0.01
Forecast
1Y Price Target
$30.00Price Target Upside13.94% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering11
EPS Forecast (FY)1.43
Revenue Forecast (FY)$2.86B
Bulls Say, Bears Say
Bulls Say
High Gross Margins & Margin ExpansionConsistently strong ~55% gross margins and recent 100bp expansion provide durable operating leverage across product lines. High gross margins support investment in R&D, pricing flexibility and margin recovery, cushioning SG&A and tariff pressures over the next several quarters.
Solid Free Cash Flow & ConversionHealthy and consistent free cash flow generation gives Envista funding optionality for organic capex, accretive tuck‑ins and the $300M buyback program. Reliable cash conversion reduces reliance on external financing and supports durable capital returns and investment over coming quarters.
Product Innovation & Diversified SegmentsBroad product portfolio and recent launches (implants, ortho, AI-enabled imaging) drive recurring consumables and equipment cycles across geographies. Diversified segment outperformance reduces single-market dependency and supports structural volume and pricing resilience over multiple quarters.
Bears Say
Thin Net Margins & Volatile EarningsLow net margins and historically volatile earnings limit the company's ability to consistently generate returns and buffer shocks. Thin profitability constrains reinvestment and raises the risk that temporary headwinds could reverse recent margin improvements within the next several quarters.
China Implants Destocking & VBP UncertaintyChannel destocking and uncertainty around volume‑based procurement in China can compress near‑term revenue and reorder patterns. Given implants' strategic importance, VBP timing and transition effects may depress growth and margin visibility across the next 2–6 months.
Tariff Costs And Elevated CapEx PressureSustained tariff headwinds and increased capital spending for new facilities strain near‑term cash flows and flexibility. Repeated negative quarterly FCF or elevated capex needs could limit ability to fund buybacks, M&A or absorb margin pressure over the coming quarters.
Envista Holdings News
NVST FAQ
What was Envista Holdings’s price range in the past 12 months?
Envista Holdings lowest stock price was $18.77 and its highest was $30.42 in the past 12 months.
What is Envista Holdings’s market cap?
Envista Holdings’s market cap is $4.44B.
When is Envista Holdings’s upcoming earnings report date?
Envista Holdings’s upcoming earnings report date is Aug 05, 2026 which is in 2 days.
How were Envista Holdings’s earnings last quarter?
Envista Holdings released its earnings results on May 06, 2026. The company reported $0.36 earnings per share for the quarter, beating the consensus estimate of $0.312 by $0.048.
Is Envista Holdings overvalued?
According to Wall Street analysts Envista Holdings’s price is currently Undervalued.
Does Envista Holdings pay dividends?
Envista Holdings does not currently pay dividends.
What is Envista Holdings’s EPS estimate?
Envista Holdings’s EPS estimate is 0.34.
How many shares outstanding does Envista Holdings have?
Envista Holdings has 162,727,920 shares outstanding.
What happened to Envista Holdings’s price movement after its last earnings report?
Envista Holdings reported an EPS of $0.36 in its last earnings report, beating expectations of $0.312. Following the earnings report the stock price went down -10.27%.
Which hedge fund is a major shareholder of Envista Holdings?
Currently, no hedge funds are holding shares in NVST
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Envista Holdings Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$30.00 (13.94% Upside)
$30.00 (13.94% Upside)
Blogger Sentiment
Bullish
NVST Sentiment 100%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Decreased
By 2.7M Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▲ 1.5%
Last 30 Days ▼ 3.6%
Last 30 Days ▼ 3.6%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
27.38%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
2.04%
Trailing 12-Months
Company Description
Envista Holdings
Envista Holdings Corporation is an enterprise dedicated to the development and distribution of a comprehensive range of dental solutions. These offerings are crucial for the identification, therapeutic intervention, and preventative care of diverse oral health issues, specifically addressing the teeth, gingiva (gums), and their supporting bone structures. The company's principal location is in Brea, California, and it maintains a workforce comprising 12,800 full-time personnel. The firm organizes its business activities into two main divisions: "Specialty Products & Technologies" and "Equipment & Consumables." The Specialty Products & Technologies division concentrates on the creation, fabrication, and promotion of sophisticated dental implant systems, advanced prosthetic devices, and their associated digital treatment software and technological advancements. This segment also provides orthodontic remedies, including bracket systems, clear aligners, and various items for dental laboratories. Conversely, the Equipment & Consumables division is responsible for conceptualizing, producing, and bringing to market a wide array of dental apparatus and vital supplies intended for professional dental clinics. This extensive catalog includes digital imaging instruments, specialized software, and visual or magnification systems; patient treatment units and other essential fixtures for dental practices; complete endodontic kits along with their complementary consumable items; materials and tools for restorative dentistry; rotary cutting tools (burs); impression-making compounds; adhesive agents and dental cements; and products designed for infection control.
NVST Company Deck
NVST Earnings Call
Q1 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call conveyed broad-based operational and commercial progress: healthy top-line growth (9.5% core, ~4% normalized), margin expansion (gross margin +100 bps, EBITDA margin +120 bps), strong EPS improvement (+50%), meaningful new-product momentum, accretive tuck-in M&A, and continued capital returns (incremental $300M buyback). Key near-term headwinds include China implant destocking ahead of VBP, elevated tariff costs (~$11M), Q1 negative FCF due to CapEx, and geopolitical-driven inflation/freight risks — all of which management has identified and presented mitigation plans for. Overall, the positives on growth, margins, product launches and capital allocation materially outweigh the manageable near-term challenges.View all NVST earnings summariesNVST Revenue Breakdown
63.99% Specialty Products & Technologies
36.01% Equipment & Consumables
NVST Stock 12 Month Forecast
Average Price Target
$30.00
▲(13.94% Upside)
Technical Analysis
DENTSPLY SIRONA
―
Disc Medicine
―
Clover Health Investments
―
AbCellera Biologics
―
Bausch + Lomb Corporation
―
Ownership Overview
0.74% Insiders
37.62% Mutual Funds
1.15% Other Institutional Investors
35.37% Public Companies and
Individual Investors